Drug development expertise and execution for early-stage biotech
Your science deserves execution that matches it.
Building a drug development programme with a lean team, under funding pressure, against investor timelines is the reality for most early-stage biotechs. The science may be strong. The question is whether it can be delivered.
Many advisors help interpret the science. Few help deliver the programme.
Every decision, every milestone, treated as if it were our own, because when it's your programme, every detail matters.
You need a CSO-level perspective on Tuesday and a CMC expert by Friday.
Drug development
The reality of early-stage drug development
Early-stage drug development demands scientific rigour and operational precision in equal measure. Teams are lean, expertise is fragmented, and the execution infrastructure is still taking shape.
The pressures are familiar
- Investors expect milestones. CROs need direction. You bridge both.
- Disconnected consultants. CROs lacking context. No one owns the whole picture.
How Linchpin works
How Linchpin supports your drug development programme
Our model integrates scientific and operational expertise into a single, managed approach. Depending on your stage and your gaps, we can move across three modes:
Assess
Rigorous, independent evaluation of your development plan, identifying risks, closing gaps, and surfacing questions your investors will ask before they ask them.
Design
A clear, capital-efficient development strategy grounded in your data, aligned to your targets, and structured around your next financing milestone, designed from the ground up for your programme.
Deliver
Hands-on operational execution across CRO selection and management, cross-functional coordination, and milestone delivery, absorbing the complexity that would otherwise slow your team down.
This is the Advise + Operate model. Strategy and execution from the same team, not passed between them.
How we work with biotech
What working with Linchpin looks like
We adapt to your stage and your team. The right scientific expertise available precisely when your programme requires it, for as long as it needs it, without the overhead of a permanent hire or the dilution that comes with building too early.
In practice, this means:
- Fractional scientific leadership - interim CSO or VP-level support
- On-demand access to specialist expertise across disciplines and modalities
- Integrated project teams assembled for your programme and stage
- CRO selection, management, and oversight - one point of accountability
- Coordination across internal teams and external partners
- Hands-on execution through key preclinical and early clinical milestones
Our consultants are experienced biotech operators who have run programmes, managed complex CRO ecosystems, and navigated investor scrutiny at every stage. They understand lean, high-pressure drug development environments because they have lived and worked in them.
Programme in focus
From pitch to panel in under 4 weeks
A biotech company with an exciting innovative platform needed therapeutic area, clinical and commercial expertise to help prioritise their pipeline targets.
Linchpin assembled a cross-functional team of experts across bioinformatics, computational chemistry, therapy area biology and commercial experts.
The company entered Series A with a defensible development plan, a coordinated CRO strategy in place, and a clear path to IND.
Outcomes
What changes when Linchpin is embedded
Credible, capital-efficient impact from concept to clinic
- Credible development strategies grounded in independent scientific expertise and built for your specific programme and stage
- Coordinated, lean programme execution across internal teams, CRO partners, and external collaborators
- Stronger investor confidence through clear, defensible scientific and operational progress
- Faster, capital-efficient progression toward the milestones that matter, without the overhead of premature hires or fragmented advisory relationships
Why Linchpin
Different from traditional biotech consultancies
Independent
No CRO, platform, or investment bias. Our judgement works in your interest.
Operators, not career consultants
We have built companies, run programmes, and made the same decisions you are making now.
Integrated
Cross-disciplinary expertise coordinated as one team, not assembled ad hoc.
Embedded
Working as part of your team, not above it.
Execution-focused
We deliver programmes, not reports.
Experience that delivers
Decades of drug development experience, applied directly to your programme
Linchpin brings together senior drug discovery and development experts with direct experience across biotech and pharmaceutical organisations. People who have led programmes, managed CRO ecosystems, and delivered milestones under the same pressures our clients face.
Here is what working with Linchpin looks like in practice:
Discuss your programme with Linchpin
Your science deserves execution that matches it. Let’s talk about what that looks like for your programme.